These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 23362136)

  • 21. Compound heterozygosity for the common sulfonylurea receptor mutations can cause mild diazoxide-sensitive hyperinsulinism.
    Dekel B; Lubin D; Modan-Moses D; Quint J; Glaser B; Meyerovitch J
    Clin Pediatr (Phila); 2002 Apr; 41(3):183-6. PubMed ID: 11999683
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Therapies and outcomes of congenital hyperinsulinism-induced hypoglycaemia.
    Banerjee I; Salomon-Estebanez M; Shah P; Nicholson J; Cosgrove KE; Dunne MJ
    Diabet Med; 2019 Jan; 36(1):9-21. PubMed ID: 30246418
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical and genetic heterogeneity of HNF4A/HNF1A mutations in a multicentre paediatric cohort with hyperinsulinaemic hypoglycaemia.
    McGlacken-Byrne SM; Mohammad JK; Conlon N; Gubaeva D; Siersbæk J; Schou AJ; Demirbilek H; Dastamani A; Houghton JAL; Brusgaard K; Melikyan M; Christesen H; Flanagan SE; Murphy NP; Shah P
    Eur J Endocrinol; 2022 Feb; 186(4):417-427. PubMed ID: 35089870
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chromosome 6q24 transient neonatal diabetes mellitus and protein sensitive hyperinsulinaemic hypoglycaemia.
    Kalaivanan P; Arya VB; Shah P; Datta V; Flanagan SE; Mackay DJ; Ellard S; Senniappan S; Hussain K
    J Pediatr Endocrinol Metab; 2014 Nov; 27(11-12):1065-9. PubMed ID: 24859512
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hyperinsulinism of infancy: novel ABCC8 and KCNJ11 mutations and evidence for additional locus heterogeneity.
    Tornovsky S; Crane A; Cosgrove KE; Hussain K; Lavie J; Heyman M; Nesher Y; Kuchinski N; Ben-Shushan E; Shatz O; Nahari E; Potikha T; Zangen D; Tenenbaum-Rakover Y; de Vries L; Argente J; Gracia R; Landau H; Eliakim A; Lindley K; Dunne MJ; Aguilar-Bryan L; Glaser B
    J Clin Endocrinol Metab; 2004 Dec; 89(12):6224-34. PubMed ID: 15579781
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ten years' experience of persistent hyperinsulinaemic hypoglycaemia of infancy.
    Tyrrell VJ; Ambler GR; Yeow WH; Cowell CT; Silink M
    J Paediatr Child Health; 2001 Oct; 37(5):483-8. PubMed ID: 11885714
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Case report: pathological features of aberrant pancreatic development in congenital hyperinsulinism due to ABCC8 mutations.
    Brunetti-Pierri N; Olutoye OO; Heptulla R; Tatevian N
    Ann Clin Lab Sci; 2008; 38(4):386-9. PubMed ID: 18988933
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Novel de novo mutation in sulfonylurea receptor 1 presenting as hyperinsulinism in infancy followed by overt diabetes in early adolescence.
    Abdulhadi-Atwan M; Bushman J; Tornovsky-Babaey S; Perry A; Abu-Libdeh A; Glaser B; Shyng SL; Zangen DH
    Diabetes; 2008 Jul; 57(7):1935-40. PubMed ID: 18390792
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Safety and efficacy of low-dose diazoxide in small-for-gestational-age infants with hyperinsulinaemic hypoglycaemia.
    Chandran S; R PR; Mei Chien C; Saffari SE; Rajadurai VS; Yap F
    Arch Dis Child Fetal Neonatal Ed; 2022 Jul; 107(4):359-363. PubMed ID: 34544689
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Randomised controlled trial of diazoxide for small for gestational age neonates with hyperinsulinaemic hypoglycaemia provided early hypoglycaemic control without adverse effects.
    Balachandran B; Mukhopadhyay K; Sachdeva N; Walia R; Attri SV
    Acta Paediatr; 2018 Jun; 107(6):990-995. PubMed ID: 29385640
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Higher C-peptide levels and glucose requirements may identify neonates with transient hyperinsulinism hypoglycemia who will benefit from diazoxide treatment.
    Davidov AS; Elkon-Tamir E; Haham A; Shefer G; Weintrob N; Oren A; Lebenthal Y; Mandel D; Eyal O
    Eur J Pediatr; 2020 Apr; 179(4):597-602. PubMed ID: 31863303
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diazoxide-responsive hyperinsulinemic hypoglycemia caused by HNF4A gene mutations.
    Flanagan SE; Kapoor RR; Mali G; Cody D; Murphy N; Schwahn B; Siahanidou T; Banerjee I; Akcay T; Rubio-Cabezas O; Shield JP; Hussain K; Ellard S
    Eur J Endocrinol; 2010 May; 162(5):987-92. PubMed ID: 20164212
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [PHHI (persistent hyperinsulinemic hypoglycemia of infancy)].
    Nagashima K
    Nihon Rinsho; 2002 Oct; 60 Suppl 10():637-40. PubMed ID: 12430295
    [No Abstract]   [Full Text] [Related]  

  • 34. Heterogeneity of persistent hyperinsulinaemic hypoglycaemia. A series of 175 cases.
    de Lonlay P; Fournet JC; Touati G; Groos MS; Martin D; Sevin C; Delagne V; Mayaud C; Chigot V; Sempoux C; Brusset MC; Laborde K; Bellane-Chantelot C; Vassault A; Rahier J; Junien C; Brunelle F; Nihoul-Fékété C; Saudubray JM; Robert JJ
    Eur J Pediatr; 2002 Jan; 161(1):37-48. PubMed ID: 11808879
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Congenital hyperinsulinism in newborn and infant].
    Giurgea I; Ribeiro MJ; Boddaert N; Touati G; Robert JJ; Saudubray JM; Jaubert F; Bellanné-Chantelot C; Brunelle F; Nihoul-Fékété C; de Lonlay P
    Arch Pediatr; 2005 Nov; 12(11):1628-35. PubMed ID: 16198094
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Persistent hyperinsulinaemic hypoglycaemia of infancy: therapy, clinical outcome and mutational analysis.
    Meissner T; Brune W; Mayatepek E
    Eur J Pediatr; 1997 Oct; 156(10):754-7. PubMed ID: 9365062
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Suppression of insulin oversecretion by subcutaneous recombinant human insulin-like growth factor I in children with congenital hyperinsulinism due to defective beta-cell sulfonylurea receptor.
    Katz LE; Ferry RJ; Stanley CA; Collett-Solberg PF; Baker L; Cohen P
    J Clin Endocrinol Metab; 1999 Sep; 84(9):3117-24. PubMed ID: 10487673
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Update of mutations in the genes encoding the pancreatic beta-cell K(ATP) channel subunits Kir6.2 (KCNJ11) and sulfonylurea receptor 1 (ABCC8) in diabetes mellitus and hyperinsulinism.
    Flanagan SE; Clauin S; Bellanné-Chantelot C; de Lonlay P; Harries LW; Gloyn AL; Ellard S
    Hum Mutat; 2009 Feb; 30(2):170-80. PubMed ID: 18767144
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical characteristics and phenotype-genotype analysis in Turkish patients with congenital hyperinsulinism; predominance of recessive KATP channel mutations.
    Demirbilek H; Arya VB; Ozbek MN; Akinci A; Dogan M; Demirel F; Houghton J; Kaba S; Guzel F; Baran RT; Unal S; Tekkes S; Flanagan SE; Ellard S; Hussain K
    Eur J Endocrinol; 2014 Jun; 170(6):885-92. PubMed ID: 24686051
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genotypes of the pancreatic beta-cell K-ATP channel and clinical phenotypes of Japanese patients with persistent hyperinsulinaemic hypoglycaemia of infancy.
    Ohkubo K; Nagashima M; Naito Y; Taguchi T; Suita S; Okamoto N; Fujinaga H; Tsumura K; Kikuchi K; Ono J
    Clin Endocrinol (Oxf); 2005 Apr; 62(4):458-65. PubMed ID: 15807877
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.